Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.
Research output: Contribution to journal › Article › peer-review
Standard Standard
Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells. / Andre, S.; Lahmann, Martina; Gabius, H.J. et al.
In: Molecular Pharmaceutics, Vol. 7, No. 6, 06.12.2010, p. 2270-2279.
In: Molecular Pharmaceutics, Vol. 7, No. 6, 06.12.2010, p. 2270-2279.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Andre, S, Lahmann, M, Gabius, HJ & Oscarson, S 2010, 'Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.', Molecular Pharmaceutics, vol. 7, no. 6, pp. 2270-2279. https://doi.org/10.1021/mp1002416
APA
Andre, S., Lahmann, M., Gabius, H. J., & Oscarson, S. (2010). Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells. Molecular Pharmaceutics, 7(6), 2270-2279. https://doi.org/10.1021/mp1002416
CBE
Andre S, Lahmann M, Gabius HJ, Oscarson S. 2010. Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells. Molecular Pharmaceutics. 7(6):2270-2279. https://doi.org/10.1021/mp1002416
MLA
Andre, S. et al. "Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.". Molecular Pharmaceutics. 2010, 7(6). 2270-2279. https://doi.org/10.1021/mp1002416
VancouverVancouver
Andre S, Lahmann M, Gabius HJ, Oscarson S. Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells. Molecular Pharmaceutics. 2010 Dec 6;7(6):2270-2279. doi: 10.1021/mp1002416
Author
RIS
TY - JOUR
T1 - Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.
AU - Andre, S.
AU - Lahmann, Martina
AU - Gabius, H.J.
AU - Oscarson, S.
PY - 2010/12/6
Y1 - 2010/12/6
U2 - 10.1021/mp1002416
DO - 10.1021/mp1002416
M3 - Article
VL - 7
SP - 2270
EP - 2279
JO - Molecular Pharmaceutics
JF - Molecular Pharmaceutics
SN - 1543-8384
IS - 6
ER -